New Concepts in Coagulation

References

• Marmur JD, Rossikhina M, Guha A. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253
   PubMed Web of Science ®Google Scholar
• Neuenschwander PF, Monisey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of Factor VlI but not cofactor function. J Biol Chem 1992; 267: 14477
   PubMedGoogle Scholar
• Rao LV, Rapaport SI. Activation of Factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988; 85: 6687
   PubMed Web of Science ®Google Scholar
• Nemerson Y, Repke D. Tissue factor accelerates the activation of Factor VII: the role of a bifunctional coagualation factor. Thromb Res 1985; 40: 351
   PubMed Web of Science ®Google Scholar
• Hoffman M, Monroe DM, Oliver JA. Factor IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794–801
   PubMedGoogle Scholar
• Kawakami S, Kaibara M, Kawamoto Y. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the eryth-rocyte surface. Biorheology 1995; 32: 521–36
   PubMedGoogle Scholar
• Ten Cate H, Blemond BJ, Levi M. Factor XIa induced activation of the intrinsic cascade. in vivo. Thromb Haemostasis 1996; 75: 445–9
   PubMedGoogle Scholar
• Kazama Y, Hamamoto T, Fosters DC. Hepsin, a putative membrane-associated serine protease. activates human Factor VII and initiates a pathway of blood-coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66–72
   PubMed Web of Science ®Google Scholar
• Lindo VS, Kakkar VV, Melissari E. Cleaved antithrombin (Atc): a new marker for thrombin generation and activation of the coagulation system. Br J Haematol 1995; 89: 157–62
   PubMedGoogle Scholar
• Wun T, Kretzmer K, Girard T. Cloning and characterization of a cDNA coding for the lipoprotein associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001–4
   PubMed Web of Science ®Google Scholar
• Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539–46
   PubMed Web of Science ®Google Scholar
• Broze GJ, Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation (review). Blood Coagulation Fibrinolysis 1995; 6: S7–1, Suppl 1
   Web of Science ®Google Scholar
• Girard TJ, Broze GJJ. Tissue factor pathway inhibitor. Methods Enzymol 1993; 222: 195–209
   PubMedGoogle Scholar
• Kisiel W. Human plasma protein C. Isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 1979; 64: 761
   PubMed Web of Science ®Google Scholar
• Regan LM, Steams-Kurosawa DJ, Kurosawa S. The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitor. J Biol Chem 1996; 271;29: 17499–503
   Google Scholar
• Bertina RM, Koeleman BP, Koster T. Mutation in blood coagulation Factor V associated with resistance to activated protein C (see comments). Nature 1994; 369: 64–7
   PubMed Web of Science ®Google Scholar
• Pryzdial ELG, Bajzar L, Nesheim E. Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation. J Biol Chem 1995; 270;30: 17871–7
   Google Scholar
• Wright JH. The origin and nature of blood platelets. Boston Med Surg J 1906; 154: 643–5
   Google Scholar
• Chapman D, Benga G. Biomembrane fluidity-studies of model and natural membranes. Biological Membranes, D. Chapman. Academic Press, London 1984; Vol. 5: 1–56
   Google Scholar
• Pollock WK, Rink T, Irvine RF. Liberation of 3H arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by conomycin and collagen. Biochem J 1986; 235: 869–77
   PubMed Web of Science ®Google Scholar
• Nurden AT. Glycoprotein defects responsible for abnormal platelet function in inherited platelet disorders. Platelet membrane glycoproreins, JN George, AT Nurden, DR Phillips. Plenum, New York 1985; 357–92
   Google Scholar
• Caen JP, Nurden AT, Jeanneau C. Bernard-Soulier syndrome, a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the Factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586–96
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 370
   Google Scholar
• Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from the prerequisite for adhesion through integrins. Cell 1991; 65: 859
   PubMed Web of Science ®Google Scholar
• Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992; 13: 100
   PubMedGoogle Scholar
• De Bruijne Admiralal LG, Modderman PW, Von dem Borne AE. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992; 80: 134
   PubMedGoogle Scholar
• Buttrum SM, Hatton R, Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 1993; 82: 1165
   PubMed Web of Science ®Google Scholar
• Yeo EL, Gemmell CH, Sutherland DR. Characterization of canine platelet P-selectin (CD 62) and its utility in flow cytometry platelet studies. Comp Biochem Physiol B 1993; 105: 625
   PubMedGoogle Scholar
• Mulligan MS, Watson SR, Fennie C. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J Immunol 1993; 151: 6410
   PubMed Web of Science ®Google Scholar
• Carolan EJ, Casale TB. Effects of neutropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol 1993; 92: 589
   PubMedGoogle Scholar
• Mulligan MS, Miyasaka M, Tamatani T. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol 1994; 152: 832
   PubMed Web of Science ®Google Scholar
• Winn RK, Liggitt D, Vedder NB. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin Invest 1993; 92: 2042
   PubMed Web of Science ®Google Scholar
• Kishimoto A, Takai Y, Mori T. Activation of calcium and phospholipid-dependent kinase by diacylglycerol: its possible relation to phosphatidyl inositol turnover. J Biol Chem 1980; 255: 2273–6
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Cooper RA. Membrane microviscosity and human platelet function. Biochemistry 1976; 15: 4832–7
   PubMed Web of Science ®Google Scholar
• Lyal F, Greer IA, Boswel F. The cell adhesion molecule VCAM-I is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation. Br J Obstet Gynaecol 1994; 101: 485–7
   PubMedGoogle Scholar
• McIntyre TM, Zimmerman GA, Satoh K. Human endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, brady-kinin and adenosine triphosphate. J Clin Invest 1985; 76: 275–80
   Google Scholar
• Bymes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome: evolving concepts of pathogenesis and therapy1 Clinics in Haematology 1986; 15: 413–42
   Google Scholar
• Mannucci PM, Lombardi R, Lattuada R. Supranormal von Willebrand factor multimers in scleroderma. Blood 1989; 74: 978–83
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholin. Nature 1980; 288: 373–6
   PubMed Web of Science ®Google Scholar
• Marcum JA, Kenny JB, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 1984; 74: 341–50
   PubMed Web of Science ®Google Scholar
• Bowie EJW. Lipid-related clotting reactions of clinical significance. Arch Pathol Lab Med 1992; 116: 1345–9
   PubMedGoogle Scholar
• Van Hinsbergh VWM. Regulation of the synthesis and secretion of plasminogen activatoars by endothelial cells. Haemostasis 1988; 18: 307–27
   PubMedGoogle Scholar
• Habib A, Maclouf J. Comparison of leukotriene A4 metabolism into leukotriene C4 by human platelets and endothelial cells. Arch Biochem Biophys 1992; 298: 1–9
   PubMedGoogle Scholar
• Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993; 7: 516–22
   PubMed Web of Science ®Google Scholar
• Marcus AJ. Eicosanoid interactions between platelets, endothelial cells, and neutrophils. Method Enzymol 1990; 187: 585–98
   PubMedGoogle Scholar
• Nicosia S, Patrano C. Eicosanoid biosynthesis and action: novel opportunities for pharmacological interventions. FASEB J 1989; 3: 1941–8
   PubMedGoogle Scholar
• Ernst E. Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic diseases. JAMA 1987; 257: 2318–24
   PubMed Web of Science ®Google Scholar
• Evangelista V, Rajtar G, De Gaetano G. Platelet activation by fMLP-stimulated polymorhonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379–88
   PubMed Web of Science ®Google Scholar
• Molino M, Blanchard N, Belmonte E. Roteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-denved cathepsin G. J Biol Chem 1995
   PubMedGoogle Scholar
• Skinner MP, Lucas CM, Bums GF. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 1991; 266: 5371–4
   PubMed Web of Science ®Google Scholar
• Colli S, Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms. J Lab Clin Med 1991; 118: 136–45
   PubMedGoogle Scholar
• Narayanan S. Reanalytical aspects of coagulation testing (review). Haematologica 1995; 80: 1–6, Suppl
   PubMedGoogle Scholar
• Bauer KA, Barzegar S, Rosenburg RD. Influence of anticoagulants used for blood collection on plasma prothrombin, fragment F1+2 measurements. Thromb Res 1991; 63: 617
   PubMedGoogle Scholar
• Weitz J, Cruikshank M, Thong B. Human tissue-type plasminogen activator releases fibnnopeptides A and B from fibrinogen. J Clin Invest 1988; 82: 1700
   PubMedGoogle Scholar
• Azola GP, Magoni M, Ascari E. Early prognostic factors in ischaemic stroke. The role of protein C and protein S. Stroke 1993; 24: 1496–500
   PubMedGoogle Scholar
• Israels SJ, Seshia SS. Childhood stroke associated with protein C or S deficiency. J Paeds 1987; 111: 562–4
   PubMedGoogle Scholar
• Kohler J, Kasper J, Witt I. Ischaemic stroke due to protein C deficiency. Stroke 1990; 21: 1077–80
   PubMedGoogle Scholar
• Faioni EM, Franchi F, Asti D. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067–71
   PubMedGoogle Scholar
• Ayuma H, Ishikawa M, Sakiyaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 80: 411
   Google Scholar
• Coller BS. Platelets in cardiovascular thrombosis and thrombolysis. The heart and cardiovascular system. 2nd ed., HA Fozzard, E Haber, RB Jennings. Raven, New York 1991; 219–74
   Google Scholar